International Equity – 1Q21 Insights & Outlook

Tag: Coronavirus

Large Cap Value - 1Q21 Insights & Outlook

Cambiar President Brian Barish answers the most pressing questions about inflation, digital currencies, and the potential risks facing U.S. equities.

SMID & Small Cap Value - 1Q 2021 Review

Cambiar SMID and Small Cap Value portfolio managers provide an update on performance and expectations going forward.

Large Cap Value - 2020 Review & 2021 Outlook

Cambiar President Brian Barish evaluates 2020 performance for the Large Cap Value portfolio and details what could be ahead for 2021.

SMID & Small Cap Value - 2020 Review

Cambiar SMID and Small Cap Value portfolio managers provide their 2020 wrap up and examine the elements that led to strong outperformance.

Coronavirus - The Mutated Strain (Q&A)

In our third Q&A segment on COVID-19, Cambiar Senior Analyst Charmaine Chan provides insights into the mutated version of the virus and the efficacy of vaccines.

Post Election & Vaccine Update

Cambiar President Brian Barish discusses what the election results and news of a potential COVID vaccine could mean to equity markets.